Место цетуксимаба в терапии метастатического рака толстой кишки

1. Гарин А.М. Рак толстой кишки. М., 1998.
2. Myers MH, Gloeckler LA. Cancer patients survival rates. CA 1989; 39: 21.
3. Wingo PA, Tong T, Bolden S. Cancer statistics. CA 1995; 45: 8 30.
4. Weitz J, Koch M, Debus J et al. Lancet 2005; 365: 153–65.
5. Tournigand C, Andre T et al. J Clin Oncol 2004; 22: 1201–8.
6. Woodburn JR. Pharmacol Ther 1999; 82: 241–50.
7. De Jong JS, van Diest PJ et al. J Pathol 1998; 184: 53–7.
8. Harary P, Huang S. Clin Cancer Res 2004; 10: 428–32.
9. Ciardiello F, Tortora G. Clin Cancer Res 2001; 7: 2958–70.
10. Moosmann N, Heinemann V. Expert Opin Biol Ther 2007; 7 (2): 243–56.
11. Prewett M et al. Clin Cancer Res 2002; 8: 994–1003.
12. Tabernero J et al. AACR 2007, abstr LB-352.
13. Tabernero J et al. JCO 2006, 24: 142s, abstr. 3085.
14. Ramanathan RK, Fakih M, Krishnamurthi SS et al. ASCO 2008, abstr. 15050.
15. Cohen D, Ma H, Yuan Y et al. ASCO 2008, abstr. 15060.
16. Bouchahda M, Macarulla T, LIedo G et al. ASCO 2008, abstr. 15118.
17. Roca J, Alonso V, Pericay C et al. ASCO 2008, abstr. 15122.
18. Elez E, Macarulla T, Tabernero J. Ann Oncol 2008; Suppl. 7: vii 146–52.
19. Bosch J, Abella L, Viudez A et al. ASCO 2008; abstr. 15096.
20. O'Callaghan CJ, Tu D, Karapetis CS et al. ASCO 2008; abstr 4130.
21. Vincenzi B, Santini D, Funaioli C et al. ASCO 2008; abstr. 4106
22. Pilon M, Mailhot M, Comtois A et al. ASCO 2008; abstr. 20755.
23. Ocvirk J, Rebersek M. ASCO 2008; abstr. 20750.
24. Ocvirk J et al. WCGIC 2009; Abstr. PD-0021.
25. Siena S et al. ASCO GI 2007; abstr. 353.
26. Finocchario G et al. JCO 2007; 25 (18S): abstr. 4021.
27. Jen J et al. Cancer Res 1994; 54: 5523–6.
28. Lievre A et al. Cancer Res 2006; 66: 3992–5.
29. Van Engeland M et al. Oncogene 2002; 21: 3792–5.
30. Lievre A, Bachet JB, Boige V et al. JCO 2008; 26: 374–9.
31. De Roock W, Piessevaux H, De Schutter J et al. Ann Oncol 2008; 19: 508–15.
32. Di Fiore F, Blanchard F, Charbonnier F et al. Br J C 2007; 96: 1166–9.
33. Karapetis CS, Khambata-Ford S, Jonker DJ et al. N Engl J Med 2008; 359: 1757–65.
34. Cunningham D, Hublet Y, Siena S et al. N E J M 2004; 351: 337–45.
35. Schuch G, Bondarenko I, Hartmann J et al. Ann Oncol 2008; 19 (Suppl. 6): vi 18 (Abstr O-032).
36. Van Cutsem E, Lang I, D'haens G et al. ASCO 2008 [2].
37. Cervantes A, Macarulla T, Martinelli E et al. ASCO 2008 [4129].
38. Bokemeyer C et al. J Clin Oncol 2009; 27 (5): 663–71.
39. Di Nicolantonio F et al. J Clin Oncol 2008; 26: 5705–12.
40. Kоhne C et al. J Clin Oncol 2009; 27 (Suppl. 15): abstr. 4068.
41. Ellis LM. Promising future biomarkers for colorectal cancer. ASCO 2009; (Ed. Book): 212–4.
42. Saltz LB, Meropol RJ et al. J Clin Oncol 2004; 22: 1201–8.
43. Lenz H-J, Mayer RJ et al. J Clin Oncol 2005; 23 (16S): abstr 3536.
44. Jonker DJ et al. Proc ASCO 2007; A LB-1.
45. Cunningham D, Hublet Y, Siena S et al. N E J M 2004; 351: 337–45.
46. Wilke H, Glynne-Jones R, Thaler J et al. J Clin Oncol 2006; 24 (18S): abstr. 3549.
47. De Cerqueira MC, Perazzo F, Simon S et al. Eur J Cancer 2007; 5 (suppl. 4): 252–3 (abstr P-3055).
48. Lim RS, Sun Y, Im SA et al. ASCO-GI 2008; abstr. 371.
49. Scheithauer W, Sobrero A, Lenz HJ et al. Eur J Cancer Suppl 2007; 5 (Suppl. 4): 235.
50. Sobrero A, Hochster H, Luppi G et al. Ann Oncol 2007; 18 (Suppl. 7): vii20.
51. Van Cutsem E, Kohne C-H, Hitre E et al. NEJM 2009; 360 (14): 1408–17.
52. Folprecht G, Gruenberger T, Hartmann JT et al. ASCO-GI 2009; abstr 296.
53. Bokemeyer C, Staroslawska E, Nowacki M et al. Eur J Cancer 2007; 5 (Suppl 4): 236 (Abstr O-3004).
54. Bokemeyer C et al. J Clin Oncol 2009; 27: 663–71.
55. Arnold D, Hobler T, Dittrich C et al. Ann Oncol 2008; 19: 1288–92.
56. Tabernero J, Van Cutsem E, Diaz-Rubio E et al. J Clin Oncol 2007; 25: 5225–32.
57. Barroso SA, Sanches E, Ferreira JM et al. ASCO 2008; abstr. 15010.
58. Ciuleanu TE, Kurteva G, Ocvirk J et al. ASCO 2008 [4032].
59. Brodowicz T, Wrba F, Koza I et al. ASCO-GI 2009 [381].
60. Heinemann V, Fisber von Weikerstbal L, Vebling-Kaiser U et al. JCO 2008; 26 (suppl.): abstr 4033.
61. Ychou et al. ASCO-GI 2009; abstr. 450.
62. Ciardello F, Bianco R, Damiano V et al. Clin Cancer Res 2000; 6: 3739–47.
63. Jung YD, Mansfield PF, Akadi M et al. Eur J Cancer 2002; 38: 1133–40.
64. Shaheen RM, Ahmad SA, Liu W et al. Br J Cancer 2001; 85: 584–9.
65. Tonra JR, Deevi DS, Corcoran E et al. Clin Cancer Res 2006; 12: 2197–207.
66. Saltz LB, Lenz H-J, Kindler HL et al. J Clin Oncol 2007; 25: 4557–61.
67. Tol J, Koopman M, Cats A et al. NEJM 2009; 360 (6): 563–72.

Е.В.Артамонова

ГУ РОНЦ им. Н.Н.Блохина РАМН, Москва